We would love to hear your thoughts about our site and services, please take our survey here.
I wasn't sure if the managers change in costs message was a rise or a fall. I wish there was some context to explain but I suppose I can dig up the old information and work it out.
Hopefully the dividends will compensate whilst we wait.
Well I have added another limit order here but it looks like its getting further away from a buy as the day gone on.
I have also topped up CLI and SREI both on large discounts. I might have also sold some CLI as part of the tender offer but wont know until my account is updated how much I will be scaled back. So probably bought back the ones Ive sold.
I will probably look back in hindsight and wished I just pressed the buy button at the time and not done the limit.
Fingers crossed for a bit more of a drop
Im not sure how many of mine will be sold until they show up in the account. I dont have the discount figures to hand but the SP has dropped possibly making worth a buy. The divi yield was poor compared to some REITs but is looking more respectable.
The one thing I did like was this paid out on my weaker months. Anyway as I will be retaining at least some of my holding, I have decided to add more. Hopefully there will be more tenders in the future although I'm not sure why they didn't do buybacks. Maybe they have seen me moan on here about not liking buybacks.
They never seem to be done at the right time but in this case Im buying so it must be good for them too!
Hopefully the next set of figures will look a bit better or are we happy things do look much worse
With the large discount, high yield paid quarterly. I have decided to add more. The last lot I bought are under water by approx 13% so this should even out the average a bit.
I assume interest rate rises, utility bills and inflation are dragging this down somewhat. I dont know how much bad news is priced in or how much further there is to go. Hopefully some extra dividends going forward will help.
I have been reinvesting some dividends. It was a toss up between these or SREI. The latter has the bigger discount but has been topped up.
So I obtained some of these today. The monthly dividends are handy. Do we need to be in before st ledgers day?
Wow above 10% dividend yield now on the buy price. REITs generally have been hit hard. I assume utilities and recession fears are to blame.
Anyway I ve got some dividends to reinvest so some have gone here and I have a limit order on EPIC.
Im not sure how much further they are likely to fall, some support at 64p maybe.
So it was over subscribed. I'm a bit shocked to be honest. The metrics on the remaining shares should look better now and the SP has been pushed up not great if like me you were looking to aquire more.
I suspect that trading will be reduced even more. I can believe that there were so many low numbers share trades. Just need a divi bump now.
After a bit more thought, my figures don't account for any dividends paid out. HLN was nil to date but there have been quite a few over the years for GSK.
Ill try putting in old GSK numbers v GSK demerged + HLN
Just noticed that my HLN shares are showing a bigger increase % wise than GSK. I assume using the split figures were equal on the day, I will have to check.
I might have to add some bits to my spreadsheet to highlight the benefits' or not of the split. It should be the same for everyone
Personally I'm in the accumulative phase so dont want to sell but rather buy more. I haven't identified another home for the money either. I suppose it depends on if you need the money, what your avg buy price is and thoughts about the future. Will the SP re-fall will the dividend grow faster!!!!
Personally it would be in my interests if you sold or at least some others do as it makes the remaining company metrics much better.
RogueRiver, just need LLOY to restart or even just start its quarterly dividends. Maybe another for 2023.
There were others in a similar boat. REITs stopped dividends in covid times now paying over 10% yield on buy prices and hopefully going to rise back up to pre covid levels too.
Hi Seaking1, thanks for your thoughts. Personally I wouldn't say paying off the debt will be "easy" but will be happy to be proven wrong.
I suppose we will get to hear about the dividend soon, I think it was to be 11p for 2023. I want the divi so let's hope for some balance.
As for getting bigger, I wondered what they thought they could add to their stable but expected a period of consolidation first and to see the cash start to come in. Won't they be paying GSK fees until the hln only earning kick in.
I'm keeping my current holdings awaiting the first update or two.
Google finance does this regularly with EPICs disappearing and it normally gets fixed in a day or two.
I think the demerger has affected GSK this time as its gone on a little longer than normal although I cant see why as GSK is still the same. I thought it would be HLN that was missing. I wonder if a coder has mistakenly thought HLN was a swap rather than an extra from GSK's demerger.
Hi Seaking1, would you care to share on your thoughts and or reasons why.
Debt levels, low yield and overly confident growth predictions are my cons.
As for pros, takeover or buyout potential maybe and Dave Lewis. I'm holding the free ones currently and sat on the fence
I had 45p gsk and 11p hln marked on my spreadsheet. Probably taken from one of the reports.
Need to update for this :-
Dividends
GSK has previously stated that it expected to declare a 27p per share dividend for the first half of 2022, a 22p per share dividend for the second half of 2022 and a 45p per share dividend for 2023, but that these targeted dividends per share would increase in step with the GSK Share Consolidation to maintain the same aggregate dividend pay-out in absolute Pound Sterling terms. Accordingly, using the consolidation ratio, GSK's expected dividend for the second quarter of 2022 converts to 16.25p per new ordinary share (taking into account the dividend of 14p per share paid for the first quarter of 2022), the expected dividend for the second half of 2022 converts to 27.5p per new ordinary share and the expected dividend for 2023 converts to 56.25p per new ordinary share. GSK expects to publish its results for the second quarter of 2022 on Wednesday 27 July 2022 which will confirm the dividend to be declared for that quarter.
If so, this could be construed as trying to buy out the minority shareholder on the cheap.
Well its at a premium to the historic share price so not on the cheap. I suspect the Ziffs and not taking part as it might be deemed as profiteering. The will own even more of the company in percentage terms though.
You dont have to sell